References
- Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003; 2:52-62; PMID: 12509759; https://doi.org/10.1038/nrd984
- Reichert JM. Monoclonal antibodies as innovative therapeutics. Curr Pharm Biotechnol 2008; 9:423-30; PMID: 19075682; https://doi.org/10.2174/138920108786786358
- Ludwig DL, Pereira DS, Zhu Z, Hicklin DJ, Bohlen P. Monoclonal antibody therapeutics and apoptosis. Oncogene 2003; 22:9097-106; PMID: 14663488; https://doi.org/10.1038/sj.onc.1207104
- Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 2004; 22:1393-8; PMID: 15529164; https://doi.org/10.1038/nbt1026
- Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J Pharm Sci 2008; 97:2426-47; PMID: 17828757; https://doi.org/10.1002/jps.21180
- Jefferis R. Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 2005; 21:11-6; PMID: 15903235; https://doi.org/10.1021/bp040016j
- Zhang W, Czupryn MJ. Free sulfhydryl in recombinant monoclonal antibodies. Biotechnol Prog 2002; 18:509-13; PMID: 12052067; https://doi.org/10.1021/bp025511z
- Dick LW, Jr., Kim C, Qiu D, Cheng KC. Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides. Biotechnol Bioeng 2007; 97:544-53; PMID: 17099914; https://doi.org/10.1002/bit.21260
- Harris RJ. Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. J Chromatogr A 1995; 705:129-34; PMID: 7620566; https://doi.org/10.1016/0021-9673(94)01255-D
- Ji JA, Zhang B, Cheng W, Wang YJ. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: Mechanisms and stabilization. J Pharm Sci 2009; 98:4485-500; PMID: 19455640; https://doi.org/10.1002/jps.21746
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem 1987; 262:785-94; PMID:3805008
- Horvat S, Jakas A. Peptide and amino acid glycation: New insights into the Maillard reaction. J Pept Sci 2004; 10:119-37; PMID: 15113085; https://doi.org/10.1002/psc.519
- Vlasak J, Ionescu R. Fragmentation of monoclonal antibodies. Mabs 2011; 3:253-63; PMID: 21487244; https://doi.org/10.4161/mabs.3.3.15608
- Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianferani S. Characterization of therapeutic antibodies and related products. Anal Chem 2013; 85:715-36; PMID: 23134362; https://doi.org/10.1021/ac3032355
- Vlasak J, Ionescu R. Heterogeneity of monoclonal antibodies revealed by Charge-Sensitive methods. Curr Pharm Biotechnol 2008; 9:468-81; PMID: 19075686; https://doi.org/10.2174/138920108786786402
- Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl 2001; 752:233-45; PMID: 11270864; https://doi.org/10.1016/S0378-4347(00)00548-X
- Gandhi S, Ren D, Xiao G, Bondarenko P, Sloey C, Ricci MS, Krishnan S. Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on Long-Term storage in a liquid formulation. Pharm Res 2012; 29:209-24; PMID: 21845507; https://doi.org/10.1007/s11095-011-0536-0
- Johnson KA, Paisley-Flango K, Tangarone BS, Porter TJ, Rouse JC. Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain. Anal Biochem 2007; 360:75-83; PMID: 17113563; https://doi.org/10.1016/j.ab.2006.10.012
- Tsubaki M, Terashima I, Kamata K, Koga A. C-terminal modification of monoclonal antibody drugs: Amidated species as a general product-related substance. Int J Biol Macromol 2013; 52:139-47; PMID: 23022270; https://doi.org/10.1016/j.ijbiomac.2012.09.016
- Gaza-Bulseco G, Bulseco A, Chumsae C, Liu H. Characterization of the glycosylation state of a recombinant monoclonal antibody using weak cation exchange chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 862:155-60; PMID: 18164669; https://doi.org/10.1016/j.jchromb.2007.12.001
- Cordoba AJ, Shyong BJ, Breen D, Harris RJ. Non-enzymatic hinge region fragmentation of antibodies in solution. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 818:115-21; PMID:15734150; https://doi.org/10.1016/j.jchromb.2004.12.033
- Saleem RA, Affholter BR, Deng SH, Campbell PC, Matthies K, Eakin CM, Wallace A. A chemical and computational approach to comprehensive glycation characterization on antibodies. Mabs 2015; 7:719-31; PMID: 26030340; https://doi.org/10.1080/19420862.2015.1046663
- Quan C, Alcala E, Petkovska I, Matthews D, Canova-Davis E, Taticek R, Ma S. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: Where it is, how it got there, and how it affects charge-based behavior. Anal Biochem 2008; 373:179-91; PMID: 18158144; https://doi.org/10.1016/j.ab.2007.09.027
- Stoll DR, Hannes DC, Danforth J, Wagner E, Guillarme D, Fekete S, Beck A. Direct identification of rituximab main isoforms and subunit analysis by online selective comprehensive Two-Dimensional liquid Chromatography-Mass spectrometry. Anal Chem 2015; 87:8307-15; PMID: 26145446; https://doi.org/10.1021/acs.analchem.5b01578